Modera Wealth Management LLC Trims Stake in The Clorox Company (NYSE:CLX)

Modera Wealth Management LLC trimmed its holdings in shares of The Clorox Company (NYSE:CLX) by 1.6% in the 3rd quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 4,631 shares of the company’s stock after selling 75 shares during the quarter. Modera Wealth Management LLC’s holdings in Clorox were worth $754,000 as of its most recent filing with the Securities & Exchange Commission.

Several other hedge funds and other institutional investors have also added to or reduced their stakes in CLX. GHP Investment Advisors Inc. boosted its stake in Clorox by 2.0% during the 2nd quarter. GHP Investment Advisors Inc. now owns 3,634 shares of the company’s stock valued at $496,000 after purchasing an additional 72 shares during the last quarter. Fiduciary Group LLC boosted its stake in Clorox by 0.4% during the 2nd quarter. Fiduciary Group LLC now owns 19,050 shares of the company’s stock valued at $2,600,000 after purchasing an additional 72 shares during the last quarter. SPC Financial Inc. boosted its stake in Clorox by 2.2% during the 2nd quarter. SPC Financial Inc. now owns 3,485 shares of the company’s stock valued at $476,000 after purchasing an additional 75 shares during the last quarter. Massmutual Trust Co. FSB ADV boosted its stake in Clorox by 17.2% during the 3rd quarter. Massmutual Trust Co. FSB ADV now owns 510 shares of the company’s stock valued at $83,000 after purchasing an additional 75 shares during the last quarter. Finally, Mesirow Financial Investment Management Inc. boosted its stake in Clorox by 5.1% during the 2nd quarter. Mesirow Financial Investment Management Inc. now owns 1,702 shares of the company’s stock valued at $233,000 after purchasing an additional 83 shares during the last quarter. 78.53% of the stock is currently owned by hedge funds and other institutional investors.

Wall Street Analyst Weigh In

Several brokerages have commented on CLX. BNP Paribas upgraded Clorox to a “strong sell” rating in a research note on Friday, September 6th. Wells Fargo & Company lowered their price target on Clorox from $135.00 to $130.00 and set an “underweight” rating on the stock in a report on Wednesday, July 10th. JPMorgan Chase & Co. increased their price target on Clorox from $148.00 to $174.00 and gave the company a “neutral” rating in a report on Friday, October 11th. Barclays increased their price target on Clorox from $130.00 to $137.00 and gave the company an “underweight” rating in a report on Friday, October 11th. Finally, Deutsche Bank Aktiengesellschaft increased their price target on Clorox from $144.00 to $151.00 and gave the company a “hold” rating in a report on Friday, August 2nd. Six analysts have rated the stock with a sell rating, nine have given a hold rating and one has issued a buy rating to the stock. According to MarketBeat.com, Clorox has a consensus rating of “Hold” and an average target price of $150.14.

Insider Activity

In other news, EVP Angela C. Hilt sold 1,733 shares of the firm’s stock in a transaction dated Friday, September 6th. The stock was sold at an average price of $165.52, for a total transaction of $286,846.16. Following the completion of the transaction, the executive vice president now owns 13,471 shares in the company, valued at $2,229,719.92. This trade represents a 0.00 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is available at the SEC website. Company insiders own 0.51% of the company’s stock.

Clorox Price Performance

NYSE:CLX opened at $157.72 on Tuesday. The company has a quick ratio of 0.63, a current ratio of 1.03 and a debt-to-equity ratio of 5.04. The business’s 50-day simple moving average is $160.91 and its two-hundred day simple moving average is $145.72. The stock has a market cap of $19.59 billion, a PE ratio of 81.72, a P/E/G ratio of 3.19 and a beta of 0.41. The Clorox Company has a 52 week low of $114.68 and a 52 week high of $169.09.

Clorox (NYSE:CLX) last issued its quarterly earnings data on Thursday, August 1st. The company reported $1.82 earnings per share for the quarter, beating analysts’ consensus estimates of $1.54 by $0.28. The firm had revenue of $1.90 billion during the quarter, compared to analyst estimates of $1.97 billion. Clorox had a return on equity of 281.12% and a net margin of 3.95%. As a group, analysts forecast that The Clorox Company will post 6.64 EPS for the current fiscal year.

Clorox Dividend Announcement

The company also recently disclosed a quarterly dividend, which will be paid on Thursday, November 7th. Stockholders of record on Wednesday, October 23rd will be given a dividend of $1.22 per share. The ex-dividend date is Wednesday, October 23rd. This represents a $4.88 dividend on an annualized basis and a dividend yield of 3.09%. Clorox’s payout ratio is 252.85%.

Clorox Profile

The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment offers cleaning products, such as laundry additives and home care products primarily under the Clorox, Clorox2, Scentiva, Pine-Sol, Liquid-Plumr, Tilex, and Formula 409 brands; professional cleaning and disinfecting products under the CloroxPro and Clorox Healthcare brands; professional food service products under the Hidden Valley brand; and vitamins, minerals and supplement products under the RenewLife, Natural Vitality, NeoCell, and Rainbow Light brands in the United States.